Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
January 2013 Volume 29 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January 2013 Volume 29 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Growth inhibition of Tax-activated human Jurkat leukemia T cells by all-trans retinoic acid requires JNK-1 inhibition

  • Authors:
    • Eduardo Parra
    • Luis Gutiérrez
  • View Affiliations / Copyright

    Affiliations: Biomedical Experimental Laboratory, Faculty of Sciences, University of Tarapaca, Arica, Chile, Faculty of Sciences, Arturo Prat University, Iquique, Chile
  • Pages: 387-393
    |
    Published online on: October 26, 2012
       https://doi.org/10.3892/or.2012.2108
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Retinoids, including vitamin A (retinol) and its analogues, are critical for a variety of biological functions. In this study, we report that all-trans retinoic acid (ATRA) decreases Jun N-terminal kinase 1 (JNK-1) activity, antagonizing the effect of the Tax protein in Jurkat leukemia T cells transiently transfected for expressing the Tax protein. The Tax protein is one of the products of the human T-cell leukemia virus type 1 (HTLV-1) which is the etiologic agent of adult T-cell leukemia (ATL), an aggressive neoplasia of CD4+ T cells. The decrease in JNK-1 activity was followed by a marked decrease in the expression of interleukin (IL)-2 and a weak increase in interferon (IFN)-γ in Jurkat cells treated with ATRA in a dose-dependent manner, suggesting a correlation between the expression of JNK-1 and the activity of the Tax protein. However, the expression levels of IL-4 and IL-10 were enhanced in cells transfected with Tax, compared with the levels in untransfected cells, but the expression levels were not affected following ATRA treatment. In transfection studies using a luciferase reporter construct expressing the IL-2 promoter or a tandem repeat of AP-1 or NF-κB, the inhibitory effect of ATRA on the IL-2 promoter and AP-1 construct was confirmed at the transcriptional level. However, the inhibitory effect in the NF-κB reporter construct was only marginal. In addition, our data demonstrated that JNK-1 is constitutively activated in Jurkat leukemia T cells expressing the Tax protein, suggesting that JNK-1 is required for Tax-induced proliferation of Jurkat leukemia cells.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD and Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 77:7415–7419. 1980. View Article : Google Scholar : PubMed/NCBI

2 

Hinuma V, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K, Shirakawa S and Miyoshi I: Adult T-cell leukemia antigen in ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 78:6476–6480. 1981. View Article : Google Scholar : PubMed/NCBI

3 

Cann AJ, Rosenblatt JD, Wachsman W, Shah NP and Chen IS: Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature. 318:571–574. 1985. View Article : Google Scholar : PubMed/NCBI

4 

Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F and Pavlakis GN: The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science. 229:675–679. 1985. View Article : Google Scholar : PubMed/NCBI

5 

Sodroski J, Rosen C, Goh WC and Haseltine W: A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus. Science. 228:1430–1434. 1985. View Article : Google Scholar : PubMed/NCBI

6 

Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG, Haseltine WA and Ramstedt U: Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol. 66:4570–4575. 1992.PubMed/NCBI

7 

Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F and Greene WC: Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sci USA. 84:5389–5393. 1987. View Article : Google Scholar : PubMed/NCBI

8 

Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR and Greene WC: HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science. 241:1652–1655. 1988. View Article : Google Scholar : PubMed/NCBI

9 

Leung KY and Nabel GJ: HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature. 333:776–778. 1988. View Article : Google Scholar : PubMed/NCBI

10 

Franchini G: Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood. 86:3619–3639. 1995.PubMed/NCBI

11 

Franklin A and Nyborg JK: Mechanisms of Tax regulation of human T cell leukemia virus type I gene expression. J Biomed Sci. 2:17–29. 1995. View Article : Google Scholar : PubMed/NCBI

12 

Bergers G, Graninger P, Braselmann S, Wrighton C and Busslinger M: Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol Cell Biol. 15:3748–3758. 1995.PubMed/NCBI

13 

Angel P and Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1072:129–157. 1991.PubMed/NCBI

14 

Fuchs SY, Xie B, Adler V, Fried VA, Davis RJ and Ronai Z: c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors. J Biol Chem. 272:32163–32168. 1997. View Article : Google Scholar : PubMed/NCBI

15 

Yao M, Nguyen TV and Pike CJ: Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci. 25:1149–1158. 2005. View Article : Google Scholar : PubMed/NCBI

16 

Widmann C, Gibson S, Jarpe MB and Johnson GL: Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 79:143–180. 1999.PubMed/NCBI

17 

Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1326–1331. 1995. View Article : Google Scholar : PubMed/NCBI

18 

Behrens A, Sibilia M and Wagner EF: Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet. 21:326–329. 1999. View Article : Google Scholar : PubMed/NCBI

19 

Zhang CC and Shapiro DJ: Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis. J Biol Chem. 275:479–486. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Yu R, Mandlekar S, Tan TH and Kong AN: Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C. J Biol Chem. 275:9612–9619. 2000. View Article : Google Scholar : PubMed/NCBI

21 

Brockes J: Developmental biology. Reading the retinoid signals. Nature. 345:766–768. 1990. View Article : Google Scholar : PubMed/NCBI

22 

Maden M: The retinoic acid supergun affair. Curr Biol. 4:281–284. 1994. View Article : Google Scholar : PubMed/NCBI

23 

O’Connell MJ, Chua R, Hoyos B, Buck J, Chen Y, Derguini F and Hammerling UJ: Retro-retinoids in regulated cell growth and death. Exp Med. 184:549–555. 1996.PubMed/NCBI

24 

Chen Y, Buck J and Derguini F: Anhydroretinol induces oxidative stress and cell death. Cancer Res. 59:3985–3990. 1999.PubMed/NCBI

25 

Duester G: Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem. 267:4315–4324. 2000. View Article : Google Scholar : PubMed/NCBI

26 

Yan JP, Garrus JE, Giebler HA, Stargell LA and Nyborg JK: Molecular interactions between the coactivator CBP and the human T-cell leukemia virus Tax protein. J Mol Biol. 281:395–400. 1998. View Article : Google Scholar : PubMed/NCBI

27 

Cantorna MT, Nashold FE, Chun TY and Hayes CE: Vitamin A down-regulation of IFN-gamma synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway. J Immunol. 156:2674–2679. 1996.PubMed/NCBI

28 

De Luca LM, Darwiche N, Celli G, et al: Vitamin A in epithelial differentiation and skin carcinogenesis. Nutr Rev. 52:S45–S52. 1994.PubMed/NCBI

29 

Thaller C and Eichele G: Identification and spatial distribution of retinoids in the developing chick limb bud. Nature. 327:625–628. 1987. View Article : Google Scholar : PubMed/NCBI

30 

Saari JC: Retinoids in photosensitive systems. The Retinoids: Biology, Chemistry, and Medicine. Sporn MB, Roberts AB and Goodman DS: 2nd edition. Raven; New York, NY: pp. 351–386. 1994

31 

Sporn MB and Roberts AB: Role of retinoids in differentiation and carcinogenesis. J Natl Cancer Inst. 73:1381–1387. 1984.PubMed/NCBI

32 

Martin SJ, Bradley JG and Cotter TG: HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol. 79:448–453. 1990. View Article : Google Scholar : PubMed/NCBI

33 

Oridate N, Lotan D, Xu XC, Hong WK and Lotan R: Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl) retinamide in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res. 2:855–863. 1996.PubMed/NCBI

34 

Sigal HN and Dumont FJ: Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Ann Rev Immunol. 10:519–560. 1992. View Article : Google Scholar : PubMed/NCBI

35 

Parra E, Varga M, Hedlund G, Kalland T and Dohlsten M: Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT binding. Mol Cell Bio. 17:1314–1323. 1997.PubMed/NCBI

36 

Parra E, McGuire K, Hedlund G and Dohlsten M: Over-expression of RelA and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter. J Immunol. 160:5374–5381. 1998.PubMed/NCBI

37 

Smeets RL, Fleuren WM, He X, Vink PM, Wijnands F, Gorecka M, Klop H, Bauerschmidt S, et al: Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signalling. BMC Immunol. 13:122012. View Article : Google Scholar

38 

Rincón M, Conze D, Weiss L, Diehl NL, Fortner KA, Yang D, Flavell RA, Enslen H, Whitmarsh A and Davis RJ: Conference highlight: do T cells care about the mitogen-activated protein kinase signalling pathways? Immunol Cell Biol. 78:166–175. 2000.PubMed/NCBI

39 

Parra E, Ortega A and Saenz L: Downregulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3. Oncol Rep. 22:1513–1518. 2009.PubMed/NCBI

40 

Parra E: Activation of MAP kinase family members triggered by TPA or ionomycin occurs via the protein phosphatase 4 pathway in Jurkat leukemia T cells. Mol Med Rep. 5:773–778. 2012.PubMed/NCBI

41 

Allende LM, Corell A, Madroño A, Góngora R, Rodríguez-Gallego C, López-Goyanes A, Rosal M and Arnaiz-Villena A: Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation. Immunology. 90:388–396. 1997. View Article : Google Scholar : PubMed/NCBI

42 

Kanno T, Franzoso G and Siebenlist U: Human T-cell leukemia virus type I Tax-protein-mediated activation of NF-kappa B from p100 (NF-kappa B2)-inhibited cytoplasmic reservoirs. Proc Natl Acad Sci USA. 91:12634–12638. 1994. View Article : Google Scholar : PubMed/NCBI

43 

Maggirwar SB, Harhaj E and Sun SC: Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor. Oncogene. 11:993–998. 1995.PubMed/NCBI

44 

Suzuki T, Hirai H, Murakami T and Yoshida M: Tax protein of HTLV-I destabilizes the complexes of NF-kappa B and I kappa B-alpha and induces nuclear translocation of NF-kappa B for transcriptional activation. Oncogene. 10:1199–1207. 1995.PubMed/NCBI

45 

Suzuki T, Hirai H and Yoshida M: Tax protein of HTLV-I interacts with the Rel homology domain of NF-kappa B p65 and a c-Rel protein bound to the NF-kappa B binding site and activates transcription. Oncogene. 9:3099–3105. 1994.PubMed/NCBI

46 

McGuire KL, Curtiss VC, Larson EL and Haseltine WA: Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression. J Virol. 67:1590–1599. 1993.PubMed/NCBI

47 

Visse E, Inostroza J, Cabello G and Parra E: The MAP kinases are differently utilized by CD28 and CD2 adhesion pathways in superantigen-activated Jurkat T cells. Biol Res. 36:263–278. 2003. View Article : Google Scholar : PubMed/NCBI

48 

Olsson C, Michaelsson E, Parra E, Pettersson U, Lando P and Dohlsten M: Biased dependency of CD80 versus CD86 in the induction of transcription factors regulating the IL-2 promoter. Int Immunol. 10:499–506. 1998. View Article : Google Scholar : PubMed/NCBI

49 

Lee W, Mitchell P and Tjian R: Purified transcriptional factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 49:741–752. 1987. View Article : Google Scholar : PubMed/NCBI

50 

Bannister A, Oehler T, Wilhelm D, Angel P and Koumanidis T: Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene. 11:2509–2514. 1995.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Parra E and Gutiérrez L: Growth inhibition of Tax-activated human Jurkat leukemia T cells by all-trans retinoic acid requires JNK-1 inhibition. Oncol Rep 29: 387-393, 2013.
APA
Parra, E., & Gutiérrez, L. (2013). Growth inhibition of Tax-activated human Jurkat leukemia T cells by all-trans retinoic acid requires JNK-1 inhibition. Oncology Reports, 29, 387-393. https://doi.org/10.3892/or.2012.2108
MLA
Parra, E., Gutiérrez, L."Growth inhibition of Tax-activated human Jurkat leukemia T cells by all-trans retinoic acid requires JNK-1 inhibition". Oncology Reports 29.1 (2013): 387-393.
Chicago
Parra, E., Gutiérrez, L."Growth inhibition of Tax-activated human Jurkat leukemia T cells by all-trans retinoic acid requires JNK-1 inhibition". Oncology Reports 29, no. 1 (2013): 387-393. https://doi.org/10.3892/or.2012.2108
Copy and paste a formatted citation
x
Spandidos Publications style
Parra E and Gutiérrez L: Growth inhibition of Tax-activated human Jurkat leukemia T cells by all-trans retinoic acid requires JNK-1 inhibition. Oncol Rep 29: 387-393, 2013.
APA
Parra, E., & Gutiérrez, L. (2013). Growth inhibition of Tax-activated human Jurkat leukemia T cells by all-trans retinoic acid requires JNK-1 inhibition. Oncology Reports, 29, 387-393. https://doi.org/10.3892/or.2012.2108
MLA
Parra, E., Gutiérrez, L."Growth inhibition of Tax-activated human Jurkat leukemia T cells by all-trans retinoic acid requires JNK-1 inhibition". Oncology Reports 29.1 (2013): 387-393.
Chicago
Parra, E., Gutiérrez, L."Growth inhibition of Tax-activated human Jurkat leukemia T cells by all-trans retinoic acid requires JNK-1 inhibition". Oncology Reports 29, no. 1 (2013): 387-393. https://doi.org/10.3892/or.2012.2108
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team